MannKind
MNKDMannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Westlake Village, California, the company was founded in February 1991. MannKind Corpo …
© Wikipedia /
Creative Commons CC-BY-SA 3.0
more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at MannKind
Subscribe RSS| Date | Type | Ø-Price | Volume |
|---|---|---|---|
| 7/17/2026 | Sell | $4.1 | $213,089 |
| 7/17/2026 | Sell | $4.0 | $97,641 |
| 5/12/2026 | Sell | $3.3 | $9,979 |
| 5/12/2026 | Sell | $3.3 | $55,733 |
| 3/10/2026 | Buy | $2.6 | $259,000 |
| 1/8/2026 | Sell | $6.3 | $297,548 |
| 12/17/2025 | Sell | $6.0 | $395,482 |
| 12/16/2025 | Sell | $6.0 | $127,860 |
| 12/12/2025 | Sell | $6.0 | $124,836 |
| 12/2/2025 | Sell | $5.6 | $823,135 |
| 12/2/2025 | Sell | $5.6 | $601,114 |
| 11/14/2025 | Sell | $5.0 | $94,448 |
| 9/16/2025 | Sell | $5.3 | $250,980 |
| 7/16/2025 | Sell | $3.9 | $29,416 |
| 7/16/2025 | Sell | $3.9 | $296,946 |
| 6/10/2025 | Sell | $4.0 | $256,340 |
| 5/20/2025 | Sell | $4.4 | $10,341 |
| 5/20/2025 | Sell | $4.4 | $53,143 |
| 5/13/2025 | Sell | $4.7 | $375,875 |
| 5/13/2025 | Sell | $4.7 | $150,598 |
| 11/22/2024 | Sell | $6.9 | $465,323 |
| 11/15/2024 | Sell | $6.8 | $456,564 |
| 11/6/2024 | Sell | $7.3 | $403,700 |
| 9/3/2024 | Sell | $6.3 | $156,500 |
| 8/30/2024 | Sell | $6.3 | $506,050 |
| 8/29/2024 | Sell | $5.9 | $32,985 |
| 8/29/2024 | Sell | $5.9 | $30,027 |
| 8/29/2024 | Sell | $6.3 | $536,168 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)